Artificial intelligence for body composition assessment focusing on sarcopenia

Abstract This study aimed to address the limitations of conventional methods for measuring skeletal muscle mass for sarcopenia diagnosis by introducing an artificial intelligence (AI) system for direct computed tomography (CT) analysis. The primary focus was on enhancing simplicity, reproducibility,...

Full description

Saved in:
Bibliographic Details
Main Authors: Sachiyo Onishi, Takamichi Kuwahara, Masahiro Tajika, Tsutomu Tanaka, Keisaku Yamada, Masahito Shimizu, Yasumasa Niwa, Rui Yamaguchi
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-83401-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544830456430592
author Sachiyo Onishi
Takamichi Kuwahara
Masahiro Tajika
Tsutomu Tanaka
Keisaku Yamada
Masahito Shimizu
Yasumasa Niwa
Rui Yamaguchi
author_facet Sachiyo Onishi
Takamichi Kuwahara
Masahiro Tajika
Tsutomu Tanaka
Keisaku Yamada
Masahito Shimizu
Yasumasa Niwa
Rui Yamaguchi
author_sort Sachiyo Onishi
collection DOAJ
description Abstract This study aimed to address the limitations of conventional methods for measuring skeletal muscle mass for sarcopenia diagnosis by introducing an artificial intelligence (AI) system for direct computed tomography (CT) analysis. The primary focus was on enhancing simplicity, reproducibility, and convenience, and assessing the accuracy and speed of AI compared with conventional methods. A cohort of 3096 cases undergoing CT imaging up to the third lumbar (L3) level between 2011 and 2021 were included. Random division into preprocessing and sarcopenia cohorts was performed, with further random splits into training and validation cohorts for BMI_AI and Body_AI creation. Sarcopenia_AI utilizes the Skeletal Muscle Index (SMI), which is calculated as (total skeletal muscle area at L3)/(height)2. The SMI was conventionally measured twice, with the first as the AI label reference and the second for comparison. Agreement and diagnostic change rates were calculated. Three groups were randomly assigned and 10 images before and after L3 were collected for each case. AI models for body region detection (Deeplabv3) and sarcopenia diagnosis (EfficientNetV2-XL) were trained on a supercomputer, and their abilities and speed per image were evaluated. The conventional method showed a low agreement rate (κ coefficient) of 0.478 for the test cohort and 0.236 for the validation cohort, with diagnostic changes in 43% of cases. Conversely, the AI consistently produced identical results after two measurements. The AI demonstrated robust body region detection ability (intersection over Union (IoU) = 0.93), accurately detecting only the body region in all images. The AI for sarcopenia diagnosis exhibited high accuracy, with a sensitivity of 82.3%, specificity of 98.1%, and a positive predictive value of 89.5%. In conclusion, the reproducibility of the conventional method for sarcopenia diagnosis was low. The developed sarcopenia diagnostic AI, with its high positive predictive value and convenient diagnostic capabilities, is a promising alternative for addressing the shortcomings of conventional approaches.
format Article
id doaj-art-9141ef80058640d589746e5809312c7f
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-9141ef80058640d589746e5809312c7f2025-01-12T12:16:36ZengNature PortfolioScientific Reports2045-23222025-01-011511910.1038/s41598-024-83401-8Artificial intelligence for body composition assessment focusing on sarcopeniaSachiyo Onishi0Takamichi Kuwahara1Masahiro Tajika2Tsutomu Tanaka3Keisaku Yamada4Masahito Shimizu5Yasumasa Niwa6Rui Yamaguchi7Department of Endoscopy, Aichi Cancer CenterDepartment of Gastroenterology, Aichi Cancer CenterDepartment of Endoscopy, Aichi Cancer CenterDepartment of Endoscopy, Aichi Cancer CenterDepartment of Endoscopy, Aichi Cancer CenterDepartment of Gastroenterology/Internal Medicine, Gifu University School of Medicine Graduate School of MedicineDepartment of Endoscopy, Aichi Cancer CenterDivision of Cancer Systems Biology, Aichi Cancer Center Research InstituteAbstract This study aimed to address the limitations of conventional methods for measuring skeletal muscle mass for sarcopenia diagnosis by introducing an artificial intelligence (AI) system for direct computed tomography (CT) analysis. The primary focus was on enhancing simplicity, reproducibility, and convenience, and assessing the accuracy and speed of AI compared with conventional methods. A cohort of 3096 cases undergoing CT imaging up to the third lumbar (L3) level between 2011 and 2021 were included. Random division into preprocessing and sarcopenia cohorts was performed, with further random splits into training and validation cohorts for BMI_AI and Body_AI creation. Sarcopenia_AI utilizes the Skeletal Muscle Index (SMI), which is calculated as (total skeletal muscle area at L3)/(height)2. The SMI was conventionally measured twice, with the first as the AI label reference and the second for comparison. Agreement and diagnostic change rates were calculated. Three groups were randomly assigned and 10 images before and after L3 were collected for each case. AI models for body region detection (Deeplabv3) and sarcopenia diagnosis (EfficientNetV2-XL) were trained on a supercomputer, and their abilities and speed per image were evaluated. The conventional method showed a low agreement rate (κ coefficient) of 0.478 for the test cohort and 0.236 for the validation cohort, with diagnostic changes in 43% of cases. Conversely, the AI consistently produced identical results after two measurements. The AI demonstrated robust body region detection ability (intersection over Union (IoU) = 0.93), accurately detecting only the body region in all images. The AI for sarcopenia diagnosis exhibited high accuracy, with a sensitivity of 82.3%, specificity of 98.1%, and a positive predictive value of 89.5%. In conclusion, the reproducibility of the conventional method for sarcopenia diagnosis was low. The developed sarcopenia diagnostic AI, with its high positive predictive value and convenient diagnostic capabilities, is a promising alternative for addressing the shortcomings of conventional approaches.https://doi.org/10.1038/s41598-024-83401-8Skeletal muscle massArtificial intelligence (AI)Sarcopenia diagnosisBody composition assessment
spellingShingle Sachiyo Onishi
Takamichi Kuwahara
Masahiro Tajika
Tsutomu Tanaka
Keisaku Yamada
Masahito Shimizu
Yasumasa Niwa
Rui Yamaguchi
Artificial intelligence for body composition assessment focusing on sarcopenia
Scientific Reports
Skeletal muscle mass
Artificial intelligence (AI)
Sarcopenia diagnosis
Body composition assessment
title Artificial intelligence for body composition assessment focusing on sarcopenia
title_full Artificial intelligence for body composition assessment focusing on sarcopenia
title_fullStr Artificial intelligence for body composition assessment focusing on sarcopenia
title_full_unstemmed Artificial intelligence for body composition assessment focusing on sarcopenia
title_short Artificial intelligence for body composition assessment focusing on sarcopenia
title_sort artificial intelligence for body composition assessment focusing on sarcopenia
topic Skeletal muscle mass
Artificial intelligence (AI)
Sarcopenia diagnosis
Body composition assessment
url https://doi.org/10.1038/s41598-024-83401-8
work_keys_str_mv AT sachiyoonishi artificialintelligenceforbodycompositionassessmentfocusingonsarcopenia
AT takamichikuwahara artificialintelligenceforbodycompositionassessmentfocusingonsarcopenia
AT masahirotajika artificialintelligenceforbodycompositionassessmentfocusingonsarcopenia
AT tsutomutanaka artificialintelligenceforbodycompositionassessmentfocusingonsarcopenia
AT keisakuyamada artificialintelligenceforbodycompositionassessmentfocusingonsarcopenia
AT masahitoshimizu artificialintelligenceforbodycompositionassessmentfocusingonsarcopenia
AT yasumasaniwa artificialintelligenceforbodycompositionassessmentfocusingonsarcopenia
AT ruiyamaguchi artificialintelligenceforbodycompositionassessmentfocusingonsarcopenia